Asset acquisition and short-term investment – related party (Details Narrative) - USD ($) |
3 Months Ended | 6 Months Ended | |||||
|---|---|---|---|---|---|---|---|
Sep. 29, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 12, 2026 |
Dec. 31, 2025 |
|
| Asset Acquisition [Line Items] | |||||||
| Share price | $ 0.94 | ||||||
| Issuance of common share | $ 348,702 | ||||||
| Equity method loss | $ 87,545 | 179,126 | |||||
| Short term investments | $ 4,503,973 | $ 4,503,973 | $ 4,683,099 | ||||
| Telomir Pharmaceuticals Inc [Member] | |||||||
| Asset Acquisition [Line Items] | |||||||
| Equity method investment ownership percentage | 5.00% | 5.00% | 10.00% | ||||
| Telomir Pharmaceuticals Inc [Member] | |||||||
| Asset Acquisition [Line Items] | |||||||
| Issuance of acquisition | 3,521,127 | ||||||
| Issuance of acquisition | $ 5,000,000 | ||||||
| Share price | $ 1.42 | ||||||
| SKNY Pharmaceuticals Inc [Member] | |||||||
| Asset Acquisition [Line Items] | |||||||
| Share price | $ 1.34 | ||||||
| Issuance of common share | $ 4,718,310 | ||||||
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The cash inflow from the additional capital contribution to the entity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Price of a single share of a number of saleable stocks of a company. No definition available.
|
| X | ||||||||||
- Definition Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Number of shares of stock issued during the period pursuant to acquisitions. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Value of stock issued pursuant to acquisitions during the period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of unrealized gain (loss) on investment. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|